Document Detail


Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine.
MedLine Citation:
PMID:  2580137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effects of nicorandil [SG-75, 2-nicotinamidoethyl nitrate (ester)] and nifedipine on the recovery of myocardial segment shortening were compared to a vehicle-treated group following a short occlusion (15 min) of the left anterior descending coronary artery (LAD) and reperfusion (5 h). The relationship between myocardial blood flow and myocardial segment shortening was examined by means of the radioactive microsphere technique and sonomicrometry. Nicorandil (100 micrograms/kg followed by 25 micrograms/kg/min, i.v.) or nifedipine (3 micrograms/kg followed by 1 microgram/kg/min, i.v.) was administered 10 min prior to and throughout the occlusion period. Both drugs produced similar decreases in mean arterial pressure (approximately 25 mm Hg) during LAD occlusion. Similar degrees of ischemia (flow deprivation) were produced in the vehicle, nicorandil, and nifedipine groups; however, nicorandil produced a significantly greater decrease in the heart rate-left ventricular systolic pressure product during coronary occlusion. During reperfusion of the LAD there was no difference in the hemodynamics of the vehicle, nicorandil, or nifedipine groups. Neither drug altered myocardial blood flow to the ischemic region during the occlusion or reperfusion period when compared to the vehicle-treated group; however, both nicorandil and nifedipine pretreatment significantly improved recovery of percentage of segment shortening of the ischemic region. Nicorandil improved the recovery of function (percentage of segment shortening) to a greater extent than did nifedipine throughout the reperfusion period, most likely because of the greater decrease in afterload produced by nicorandil.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
K A Lamping; G J Gross
Related Documents :
12932117 - Cilnidipine as an agent to lower blood pressure without sympathetic nervous activation ...
6734917 - Effect of pindolol and nifedipine alone and in combination on haemodynamic parameters/v...
7317897 - Evaluation of effect of drugs on the exercise ecg.
7504127 - Hemodynamic and antiischemic effects of nifedipine, lacidipine, and nisoldipine in rat ...
14717927 - Temporary losartan or captopril in young shr induces malignant hypertension despite ini...
15827937 - Blunted heart rate response to upright tilt in people with down syndrome.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  7     ISSN:  0160-2446     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:    1985 Jan-Feb
Date Detail:
Created Date:  1985-05-16     Completed Date:  1985-05-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  158-66     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Calcium / metabolism
Coronary Circulation / drug effects
Coronary Disease / physiopathology*
Dogs
Female
Heart / physiopathology*
Hemodynamics / drug effects
Male
Niacinamide / analogs & derivatives*,  pharmacology
Nicorandil
Nifedipine / pharmacology*
Vasodilator Agents / pharmacology*
Grant Support
ID/Acronym/Agency:
HL 08311/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Vasodilator Agents; 21829-25-4/Nifedipine; 65141-46-0/Nicorandil; 7440-70-2/Calcium; 98-92-0/Niacinamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular effects of the metabolites of diltiazem in dogs.
Next Document:  Sympathetic control of myocardial oxygen balance in dogs mediated by activation of coronary vascular...